Vera Therapeutics, Inc.
Vera Therapeutics, Inc. (VERA) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
vera · stock forecast · 14 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 14 Wall Street analysts in the past 3 months
Buy
14 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$91.00
Consensus
$68.50
+115.7% upside
Low
$33.00
Median: $75 · Last Close: $31.75
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$68.50
115.7% upside
High Target
$91
186.6%
Low Target
$33
3.9%
Current Price
$31.75
as of today
Based on analyst price targets, the VERA stock price prediction for the next 12 months ranges from $33 to $91. The consensus VERA price forecast of $68.50 implies 115.7% upside from the current price of $31.75.
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $30.16 | ↓ 5.00% |
1-day model range: $29.96–$30.37. Peak: $30.37 (-5.00%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $29 | -9.1% |
| 2028 | $27 | -14.0% |
| 2029 | $26 | -16.8% |
| 2030 | $26 | -18.5% |
| 2031 | — | -19.4% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · VERA · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-15 | Evercore ISI Group | Maintains | Outperform→Outperform |
| 2026-03-11 | Wolfe Research | Upgrade ↑ | Peer Perform→Outperform |
| 2026-03-02 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-12-19 | Goldman Sachs | Maintains | Buy→Buy |
| 2025-12-19 | B of A Securities | Maintains | Buy→Buy |
| 2025-12-19 | JP Morgan | Maintains | Overweight→Overweight |
| 2025-12-11 | Wedbush | Maintains | Neutral→Neutral |
| 2025-12-08 | Evercore ISI Group | Maintains | Outperform→Outperform |
| 2025-12-05 | TD Cowen | Maintains | Buy→Buy |
| 2025-11-10 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Vera Therapeutics, Inc. (VERA) stock. Of the recent 59 rating actions, 3 were upgrades and 3 were downgrades. 14 analysts currently cover VERA.
Analyst Recommendation Trends
VERA analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$35M
↓ 94.6% YoY
Revenue Next Year
$254M
↑ 616.1% YoY
EPS This Year
$-6.10
EPS Next Year
$-3.73
↓ 38.9% YoY
EPS ForecastReported vs Estimated
Analysts forecast VERA EPS of $-6.10 for the current fiscal year, based on estimates from 8 analysts. The VERA revenue forecast is $35M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The VERA stock forecast is supported by two independent data sources: analyst consensus ratings from 14 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus VERA price target is $68.50 (+115.7% upside), with an analyst consensus of Buy.
The VERA short-term stock prediction for tomorrow is $30.16 (-5.00%). The VERA stock price prediction for 2027 estimates an average of $29. The VERA stock prediction for 2030 projects a range of $24–$28.
Vera Therapeutics, Inc. trades on NASDAQ under the ticker VERA. The VERA stock outlook for 2027 is broadly positive, supported by a Buy consensus among 93% of covering analysts.
Frequently asked questions
VERA forecast · 8 questionsAccording to 14 Wall Street analysts, the average 12-month VERA price target is $68.50, with a high forecast of $91.00 and a low of $33.00. The median price target is shown in the chart above when available. This implies +115.7% potential upside from the current price of $31.75.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.